Data through FY2026 Q3 (Jun 30, 2026)
Ultragenyx Pharmaceutical, Inc.
Company profile for Ultragenyx Pharmaceutical, Inc. covers 28 filings across the reporting window. FY2026 certified median offer: $145,029.
- FY2026 certified median
- $145,029
- Total filings
- 28
- FY2026 25th–75th percentile
- $140,733–$163,457
- Top job title
- Manager, Quality Assurance
| Fiscal year | Filings | Median | 25th percentile | 75th percentile |
|---|---|---|---|---|
| FY2024 | 10 | $159,462 | $137,072 | $181,813 |
| FY2025 | 11 | $149,131 | $128,000 | $185,135 |
| FY2026 (Q1–Q3) | 7 | $145,029 | $140,733 | $163,457 |
FY2026 is partial (*). Its filing totals are not comparable to a full fiscal year.
Median offer by fiscal year
Top titles
- Manager, Quality Assurance2 filings
- Medical Director, Global Clinical Development (Neurology)2 filings
- Assoc. Director, Technical Project Management - Gene Therapy1 filings
- Associate Director, Quality Assurance Operations Downstream1 filings
- Associate Director, Quality Control Systems1 filings
- Associate Director, Regulatory Affairs CMC1 filings
- Associate Director, Upstream Process Development1 filings
- Director, Business Operations1 filings
- Director Program Management1 filings
- Director, Quality Control1 filings
Top cities
- Bedford11 filings
- Brisbane3 filings
- Sommerville3 filings
- Woburn3 filings
- Somerville2 filings
- Novato1 filings
- South San Francisco1 filings
- Westfield1 filings
- Boston1 filings
- Cambridge1 filings